Clinical Trial Update: Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder [Phase 4]

View source ↗

Summary

This document reports a Phase 4 open-label extension study of licarbazepine for manic episodes in Bipolar I disorder. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Licarbazepine (licarbazepine)

Snippet

Sponsor: Novartis | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED